Valeant Pharmaceuticals declines after downgrade
Valeant Pharmaceuticals International declined Thursday after being downgraded.
Arch Coal was downgraded by equities research analysts at Citigroup to a ``neutral'' rating in a research note issued to investors on Monday, Analyst Ratings Network.com reports.